Aequus Pharmaceuticals Inc. (AQS.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 254.89 Thousand | 1.37 Million | 2.71 Million | 2.59 Million | 1.63 Million | 1.41 Million |
| Cost of Revenue | 249.39 Thousand | 233.39 Thousand | 25.77 Thousand | - | - | - |
| Gross Profit | 5499.00 | 1.14 Million | 2.68 Million | 2.59 Million | 1.63 Million | 1.41 Million |
| Operating Expenses | 2.96 Million | 3.64 Million | 4.05 Million | 3.11 Million | 3.85 Million | 4.21 Million |
| Selling, General and Administrative Expenses | 2.52 Million | 3.47 Million | 3.63 Million | 2.96 Million | 3.63 Million | 3.69 Million |
| Research and Development Expenses | 301.28 Thousand | 168.71 Thousand | 296.84 Thousand | 54.6 Thousand | 210.82 Thousand | 526.93 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.07 Million | 3.87 Million | 4.08 Million | 3.11 Million | 3.85 Million | 4.21 Million |
| Operating Income | -2.82 Million | -2.49 Million | -1.35 Million | -521.57 Thousand | -2.2 Million | -2.8 Million |
| Interest Expense | 145.18 Thousand | 214 Thousand | 454.84 Thousand | 519.59 Thousand | 418.66 Thousand | - |
| Income Tax Expense | - | -1.00 | 454.84 Thousand | 519.59 Thousand | 418.66 Thousand | -4289.00 |
| Earnings before Tax | -2.96 Million | -3.21 Million | -1.8 Million | -1.04 Million | -3.1 Million | -2.8 Million |
| Net Income | -2.96 Million | -3.21 Million | -1.8 Million | -1.04 Million | -3.1 Million | -2.8 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.01 | -0.01 | -0.04 | -0.04 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.04 | -0.04 |
| Weighted Average Shares Outstanding | 132.63 Million | 132.63 Million | 128.84 Million | 93.18 Million | 80.42 Million | 75.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.63 Million | 132.63 Million | 128.84 Million | 93.18 Million | 80.42 Million | 75.64 Million |
| Gross Margin | 0.02 | 0.83 | 0.99 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -10.52 | -1.72 | -0.45 | -0.12 | -1.16 | -1.86 |
| Profit Margin | -11.63 | -2.33 | -0.67 | -0.40 | -1.90 | -1.99 |
| EBITDA | -2.68 Million | -2.86 Million | -1.22 Million | -314.79 Thousand | -2.37 Million | -2.61 Million |
| Earnings Before Tax Margin | -11.06 | -1.81 | -0.50 | -0.20 | -1.35 | -1.99 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 161.41 Thousand | 52.55 Thousand | 254.89 Thousand | 50.87 Thousand | 13.35 Thousand | 98.4 Thousand |
| Cost of Revenue | 86.56 Thousand | 50.67 Thousand | 249.39 Thousand | 49.22 Thousand | 45.2 Thousand | 81.22 Thousand |
| Gross Profit | 74.85 Thousand | 1882.00 | 5499.00 | 1653.00 | -31.84 Thousand | 17.18 Thousand |
| Operating Expenses | 736.56 Thousand | 612.42 Thousand | 2.82 Million | 667.05 Thousand | 740.07 Thousand | 685.23 Thousand |
| Selling, General and Administrative Expenses | 736.56 Thousand | 612.42 Thousand | - | 667.05 Thousand | 665.98 Thousand | 659.41 Thousand |
| Research and Development Expenses | - | - | - | - | 74.09 Thousand | 25.82 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 823.12 Thousand | 663.09 Thousand | 3.07 Million | 716.27 Thousand | 785.28 Thousand | 766.46 Thousand |
| Operating Income | -661.71 Thousand | -610.54 Thousand | -2.82 Million | -665.4 Thousand | -771.93 Thousand | -668.06 Thousand |
| Interest Expense | - | 52.33 Thousand | 145.18 Thousand | 47.64 Thousand | 35.78 Thousand | 32.26 Thousand |
| Income Tax Expense | -2.00 | -2.00 | -3.00 | -1.00 | 3.00 | 3.00 |
| Earnings before Tax | -683.03 Thousand | -662.08 Thousand | -2.96 Million | -715.87 Thousand | -803.65 Thousand | -700.87 Thousand |
| Net Income | -683.03 Thousand | -662.08 Thousand | -2.96 Million | -715.87 Thousand | -803.65 Thousand | -700.87 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 132.65 Million | 132.63 Million | 132.63 Million | 132.63 Million | 132.63 Million | 132.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.63 Million | 132.63 Million | 132.63 Million | 132.63 Million | 132.63 Million | 132.63 Million |
| Gross Margin | 0.46 | 0.04 | 0.02 | 0.03 | -2.38 | 0.17 |
| EBIT Margin | -4.09 | -10.99 | - | -12.41 | -55.18 | -6.44 |
| Profit Margin | -4.23 | -12.60 | -11.63 | -14.07 | -60.16 | -7.12 |
| EBITDA | -660.25 Thousand | -577.46 Thousand | - | -631.48 Thousand | -737.18 Thousand | -633.31 Thousand |
| Earnings Before Tax Margin | -4.10 | -11.62 | -11.06 | -13.08 | -57.78 | -6.79 |
INFOBEAN
002685
GRLF
6918
UTTAMSUGAR
298540